EXECUTIVE CHANGE IN CONTROL AND SEVERANCE AGREEMENTExecutive Change in Control and Severance Agreement • May 22nd, 2020 • Vaxcyte, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledMay 22nd, 2020 Company Industry JurisdictionThis Executive Severance Agreement (the “Agreement”) is entered into by and between (the “Executive”) and Vaxcyte, Inc., a Delaware corporation (the “Company”), effective as of the Effective Date (as defined below).